Ionis Pharmaceuticals Inc (IONS)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$31.00
Buy
$34.00
$0.57 (+1.73%)
Prices updated at 16 May 2025, 23:04 EDT
| Prices minimum 15 mins delay
Prices in USD
Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 98.41 |
| 2023 | 98.84 |
| 2022 | 97.60 |
| 2021 | 98.66 |
| 2020 | 98.36 |
| 2019 | 99.61 |
| 2018 | 99.70 |
| 2017 | 100.00 |
| 2016 | 100.00 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 7.15 |
| 2024 | 6.36 |
| 2023 | 11.75 |
| 2022 | 6.11 |
| 2021 | 6.48 |
| 2020 | 8.51 |
| 2019 | 10.54 |
| 2018 | 12.46 |
| 2017 | 12.66 |
| 2016 | 24.29 |
| 2015 | 23.45 |
Price/Forward earnings (YTD)
-11.00
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -15.15 |
| 2023 | -13.26 |
| 2022 | -10.48 |
| 2021 | -1.14 |
| 2020 | -15.80 |
| 2019 | 9.43 |
| 2018 | 13.88 |
| 2017 | 1.68 |
| 2016 | -6.49 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 5.11 |
| 2023 | 7.73 |
| 2022 | 4.42 |
| 2021 | 3.38 |
| 2020 | 3.22 |
| 2019 | 2.20 |
| 2018 | 2.55 |
| 2017 | 4.71 |
| 2016 | 9.16 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
